'For quarter ending June 2024, standalone Net sales (including other operating income) of Abbott India has increased 5.32% to Rs 1,557.61 crore compared to quarter ended June 2023.
Operating profit margin has jumped from 24% to 25.10%, leading to 10.14% rise in operating profit to Rs 391.01 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 10.54% to 8.93%. Purchase of finished goods cost rose from 42.46% to 47.67%. Employee cost decreased from 10.72% to 9.83%. Other expenses fell from 10.83% to 9.71%.
Other income up 20.23% to Rs 67.33 crore. PBIDT rose 11.52% to Rs 458.34 crore. Provision for interest fell 17.66% to Rs 2.75 crore.
PBDT rose 11.76% to Rs 455.59 crore. Provision for depreciation rose 6.99% to Rs 18.37 crore.
Profit before tax grew 11.97% to Rs 437.22 crore. Provision for tax was ...
Pleaselogin & subscribe to view the full report.
More Reports
|
|
-
Results-Analysis (05-Feb-2025)
Abbott India
PAT surged 16.01%
-
Results-Analysis (07-Nov-2024)
Abbott India
OP increased 15.25%
-
Results-Analysis (08-Aug-2024)
Abbott India
PAT up 13.01%
-
Results-Analysis (10-May-2024)
Abbott India
OP up 17.64%
|
|